Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antiviral APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN103402973A details a shikimic acid-free route for Tamiflu precursors, offering supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN1594287A details a low-pressure condensation route for cytosine precursors, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Advanced preparation method for Baloxavir Marboxil featuring n-pentyl protection. Delivers high purity, reduced costs, and scalable supply chain solutions for global pharmaceutical partners.
Advanced patent CN103848868B details high-yield tenofovir production ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN111233869B reveals a novel route for Remdesivir intermediates using masked pyrrolo-triazines, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN111116693B reveals a novel Grignard activation method reducing by-products. Achieve high-purity sofosbuvir manufacturing with significant cost reduction and supply reliability.
Advanced stereospecific synthesis of beta-thymidine via CN1055293C. Offers cost reduction in API manufacturing with high purity and scalable industrial processes.
Patent CN115232055A reveals a green one-pot synthesis for Arbidol Hydrochloride, offering significant cost reduction and enhanced supply chain reliability for pharmaceutical manufacturers.
Patent CN115784968A reveals a safer sulfur ylide route for Formula 1, offering high yields and scalable manufacturing for reliable pharmaceutical intermediate suppliers.
Patent CN110698358A reveals a continuous flow method for oseltamivir phosphate, offering significant yield improvements and safety enhancements for pharmaceutical manufacturers.
Advanced synthesis of (R)-9-(2-hydroxypropyl) adenine via selective acetylation. High-yield route for Tenofovir intermediates ensuring cost reduction and supply reliability.
Patent CN113307744A reveals a high-purity oseltamivir phosphate method. Discover cost-effective manufacturing and supply chain advantages for antiviral APIs.
Advanced synthesis of Remdesivir intermediates via optimized cyanation and ammonolysis. Reduces waste and improves scalability for pharmaceutical manufacturing.
Patent CN114685558A reveals a high-yield preparation method for Remdesivir intermediate Compound I, offering significant cost reduction and supply chain reliability for global API manufacturers.
Patent CN113880846A details a low-cost route for antiviral intermediates. Achieve high purity >99% with reduced waste and simplified processing for scalable manufacturing.
Patent CN113214322B details a green preparation of Tenofovir using rare-earth doped solid super acids, offering reduced corrosion and wastewater for API manufacturers.
Novel synthesis route replaces hazardous reagents with safer alternatives, ensuring high purity and cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN110041369A details a high-purity synthesis route for Tenofovir Disoproxil Fumarate, offering significant supply chain stability and cost reduction benefits for API manufacturing.
Novel 4-step synthesis of Oseltamivir Phosphate using Ritter reaction. High yield, mild conditions, and cost-effective API manufacturing solution for global supply chains.
Patent CN115417767A reveals a mild, oxidation-free route for Caronic Anhydride, offering significant cost reduction and supply chain reliability for Paxlovid manufacturers.